Rodman's rebirth

Rodman & Renshaw hopes to reestablish itself as a major player in small cap biotech banking following a planned management-led buyout, according to Michael Vasinkevich, a Rodman co-founder, senior managing director and vice chairman.

In June, Rodman's parent company changed its name to Direct Markets Holdings Corp. (NASDAQ:MKTS) and in May said it was exploring strategic alternatives for the Rodman & Renshaw investment bank...